ASML vs DHR: Which Is the Better Buy?
Side-by-side comparison of ASML Holding N.V. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
ASML Holding N.V. · Technology
$1,458.97
+65.1% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
ASML has more upside to fair value
(+65.1%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ASML |
DHR |
| Current Price |
$1,458.97 |
$174.04 |
| Fair Value Estimate |
$2,408.73 |
$197.01 |
| Upside to Fair Value |
+65.1%
|
+13.2%
|
| Market Cap |
$562.3B |
$123.2B |
| Forward P/E |
48.3x
|
33.4x
|
| EV / EBITDA |
37.6x
|
20.3x
|
| Price / Sales |
14.4x
|
5.0x
|
| Price / FCF |
54.4x
|
23.3x
|
| Revenue Growth YoY |
+13.2%
|
+3.7%
|
| Gross Margin |
52.6%
|
60.7%
|
| Operating Margin |
34.8%
|
21.0%
|
| Return on Equity |
52.0%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.84%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ASML Holding N.V. is a leading technology company specializing in semiconductor manufacturing equipment, particularly extreme ultraviolet lithography machines which hold a near-monopoly position. The company benefits from a durable competitive moat driven by its technological leadership, high barriers to entry, and strong demand from semiconductor manufacturers globally, especially in China. Desp…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
ASML |
DHR |
| Zone Low |
$1,806.55 |
$147.76 |
| Zone High |
$2,047.42 |
$167.46 |
| In Buy Zone? |
Yes
|
No
|